Your Source for Venture Capital and Private Equity Financings

Venture Capital News: 64x Bio Raises $55M Series A

2022-01-20
SAN FRANCISCO, CA, 64x Bio, a synthetic biology company, announced the close of a $55 million Series A financing round led by Lifeforce Capital.
64x Bio, a synthetic biology company, announced the close of a $55 million Series A financing round.

The Series A financing was led by Lifeforce Capital, with significant participation from Northpond Ventures, individual investor Michael Chambers (co-founder and former CEO of Aldevron), Future Ventures, and insider First Round Capital. Chris Gibson (co-founder and CEO of Recursion), Alix Ventures, as well as previous investors, Fifty Years, SV Angel, BoxGroup, and Refactor Capital, also participated in the oversubscribed round.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors